Dementia Care

Nursing home activity directors can use this document to review steps that could help residents with dementia improve nighttime sleep.

The last few years have brought a groundbreaking trend in care for nursing home residents living with dementia. Learn how Garden Terrace Alzheimer's Center for Excellence cut the number of residents receiving antipsychotics in half.

Providing information about antipsychotic medication indications, appropriate age groups, off-label uses, side effects, adverse effects and black box warnings, this medication reference guide is a useful reference in prescribing and monitoring antipsychotic medication.

This brief video will give you an opportunity to explore how well you know your residents and what you might use to help them be happy in your facility.

Are you interested in becoming a Certified Dementia Practitioner? This website provides information on how to obtain certification.

This toolkit, developed by the Centers for Medicare & Medicaid Services (CMS), focuses on providing nurse aides quality training on abuse prevention and person-centered care of residents with dementia, but may be beneficial to nursing home caregivers, administrative staff and surveyors also. The training materials consist of six one-hour training videos, orientation guide and instructor guide. Please note that contact information is required to access the downloadable materials.

Minimum Data Set (MDS) training is available in both Sections C and D, Cognitive & Mood Assessment. Training includes the updated "BIMS Video Tutorial." Scroll down the page to locate the materials for Sections C & D.

The California Partnership to Improve Dementia Care created six videos focused on COVID-19 and residents living with dementia. Topics include Activities for Patients with Dementia, Coping and Stress Management During a Pandemic, Tips for Reducing Emotional Distress in Patients with Dementia, How to Reduce Wandering in Patients with Dementia, Optimizing Dementia Care, and Optimizing Person-Centered and Family Dementia Care.

On Monday, June 11, 2024, an advisory panel to the U.S. Food and Drug Administration (FDA) unanimously approved the use of donanemab, a monoclonal antibody treatment, to help slow the progression of Alzheimer’s disease.

This article focuses on the effects of music on long-term residents and provides tips for long-term care staff when using music.

This document acknowledges challenges to and provides strategies for preventing the spread of COVID-19 among long-term community residents living with dementia.

Use this toolkit to make the case for improving dementia care, implementing quality improvement, and training clinicians from all disciplines to better support people living with dementia and their caregivers.

This Oct. 19 recording features Dr. Angela Norman, author of the “Well-being Model for Dementia Care in the Long-term Care Setting,” discussing antipsychotic medications and why it is important to reduce the use of these medications. She also explores alternative avenues for treating residents with dementia.

On July 2, 2024, the Centers for Medicare & Medicaid Services announced that Medicare coverage is now available for Kisunla (donanemab-azbt) following the Food and Drug Administration's (FDA) move to grant traditional approval to the drug that treats people with Alzheimer’s disease. Kisunla joins Leqembi (the brand name for lecanemab-irmb) as the second monoclonal amyloid beta antibody treatment granted traditional FDA approval for Alzheimer’s disease.

This mini-toolkit includes resources geared toward improving medication safety.

Visit this website to access a variety of resources to help providers with dementia care including assessments, guidelines, handouts, trainings and more.

In this Nov. 22, 2022, recording, TMF Quality Innovation Network-Quality Improvement Organization (QIN-QIO) specialists provide information on caring for residents with cognitive impairments while keeping them safe.

This toolkit, prepared for the Commonwealth Fund in collaboration with the Hartford Foundation, provides information on non-pharmacological approaches that are effective in reducing the behavioral and psychological symptoms of dementia exhibited by persons residing in nursing homes.

The COE-NF serves as a centralized hub and national model for expanding capacity in nursing facilities to care for residents with a variety of behavioral health needs. Training, technical assistance and workforce development will be provided for staff in nursing facilities.

This article shares some reasons why people with dementia resist wearing masks (e.g., post-war trauma) and also provides tips on how to help overcome that resistance.